2,2'-dipyridyl has been researched along with Breast Neoplasms in 11 studies
2,2'-Dipyridyl: A reagent used for the determination of iron.
2,2'-bipyridine : A bipyridine in which the two pyridine moieties are linked by a bond between positions C-2 and C-2'.
Breast Neoplasms: Tumors or cancer of the human BREAST.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this work, Complex IV was observed to be the most active ruthenium bipyridine complex against the mammalian breast cancer cells MCF-7 and MDA-MB231: it was approximately twice as active as cisplatin, whilst complexes I-III proved to be less cytotoxic than complex IV." | 8.02 | Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents. ( Carneiro, ZA; Carvalho, I; da Silva, RS; de Carvalho, MR; de Souza, GA; Ferreira, LP; Formiga, ALB; Gaspari, APS; Pernomian, L; Ramos, LCB, 2021) |
| "The cancer chemotherapeutic potential of surfactant-cobalt(III) complexes, cis-[Co(bpy)(2)(C(14)H(29)NH(2))Cl](ClO(4))(2)·3 H(2)O (1) and cis-[Co(phen)(2)(C(14)H(29)NH(2))Cl](ClO(4))(2)·3 H(2)O (2) (bpy = 2,2'-bipyridine, phen = 1,10-phenanthroline) on MCF-7 breast cancer cell was determined adopting MTT assay and specific staining techniques." | 7.77 | Cytotoxic property of surfactant-cobalt(III) complexes on a human breast cancer cell line. ( Akbarsha, MA; Arunachalam, S; Dinesh, M; Krishnamurthy, H; Kumar, RS; Paul, CP; Riyasdeen, A; Srinag, S, 2011) |
| " In this work, Complex IV was observed to be the most active ruthenium bipyridine complex against the mammalian breast cancer cells MCF-7 and MDA-MB231: it was approximately twice as active as cisplatin, whilst complexes I-III proved to be less cytotoxic than complex IV." | 4.02 | Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents. ( Carneiro, ZA; Carvalho, I; da Silva, RS; de Carvalho, MR; de Souza, GA; Ferreira, LP; Formiga, ALB; Gaspari, APS; Pernomian, L; Ramos, LCB, 2021) |
| "The cancer chemotherapeutic potential of surfactant-cobalt(III) complexes, cis-[Co(bpy)(2)(C(14)H(29)NH(2))Cl](ClO(4))(2)·3 H(2)O (1) and cis-[Co(phen)(2)(C(14)H(29)NH(2))Cl](ClO(4))(2)·3 H(2)O (2) (bpy = 2,2'-bipyridine, phen = 1,10-phenanthroline) on MCF-7 breast cancer cell was determined adopting MTT assay and specific staining techniques." | 3.77 | Cytotoxic property of surfactant-cobalt(III) complexes on a human breast cancer cell line. ( Akbarsha, MA; Arunachalam, S; Dinesh, M; Krishnamurthy, H; Kumar, RS; Paul, CP; Riyasdeen, A; Srinag, S, 2011) |
| "Human breast carcinoma MDA-MB-231 cells were loaded on the surface of a type I collagen gel in the well of 8-well chamber slide and allowed to migrate into the gel." | 1.40 | Migration of breast cancer cells into reconstituted type I collagen gels assessed via a combination of frozen sectioning and azan staining. ( Fujita-Yamaguchi, Y; Fukuda, K; Kamoshida, Y; Kurokawa, T; Nakata, M; Yoshida, M, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Schwarze, B | 1 |
| Jelača, S | 1 |
| Welcke, L | 1 |
| Maksimović-Ivanić, D | 1 |
| Mijatović, S | 1 |
| Hey-Hawkins, E | 1 |
| Gaspari, APS | 1 |
| da Silva, RS | 1 |
| Carneiro, ZA | 1 |
| de Carvalho, MR | 1 |
| Carvalho, I | 1 |
| Pernomian, L | 1 |
| Ferreira, LP | 1 |
| Ramos, LCB | 1 |
| de Souza, GA | 1 |
| Formiga, ALB | 1 |
| Bernardes, JR | 1 |
| Faria, CC | 1 |
| Andrade, IS | 1 |
| Ferreira, ACF | 1 |
| Carvalho, DP | 1 |
| Leitão, AC | 1 |
| de Alencar, TAM | 1 |
| Fortunato, RS | 1 |
| Vo, V | 1 |
| Tanthmanatham, O | 1 |
| Han, H | 1 |
| Bhowmik, PK | 1 |
| Spangelo, BL | 1 |
| Filho, JC | 1 |
| Sarria, AL | 1 |
| Becceneri, AB | 1 |
| Fuzer, AM | 1 |
| Batalhão, JR | 1 |
| da Silva, CM | 1 |
| Carlos, RM | 1 |
| Vieira, PC | 1 |
| Fernandes, JB | 1 |
| Cominetti, MR | 1 |
| Fukuda, K | 1 |
| Kamoshida, Y | 1 |
| Kurokawa, T | 1 |
| Yoshida, M | 1 |
| Fujita-Yamaguchi, Y | 1 |
| Nakata, M | 1 |
| Shahsavar, F | 1 |
| Bozorgmehr, M | 1 |
| Mirzadegan, E | 1 |
| Abedi, A | 1 |
| Lighvan, ZM | 1 |
| Mohammadi, F | 1 |
| Safari, N | 1 |
| Amani, V | 1 |
| Zarnani, AH | 1 |
| Liu, YJ | 1 |
| Liang, ZH | 1 |
| Li, ZZ | 1 |
| Yao, JH | 1 |
| Huang, HL | 1 |
| Kumar, RS | 1 |
| Riyasdeen, A | 1 |
| Dinesh, M | 1 |
| Paul, CP | 1 |
| Srinag, S | 1 |
| Krishnamurthy, H | 1 |
| Arunachalam, S | 1 |
| Akbarsha, MA | 1 |
| Bertolesi, GE | 1 |
| Trigoso, CI | 1 |
| Espada, J | 1 |
| Stockert, JC | 1 |
| Ward, MC | 1 |
| Roberts, KR | 1 |
| Westwood, JH | 1 |
| Coombes, RC | 1 |
| McCready, VR | 1 |
11 other studies available for 2,2'-dipyridyl and Breast Neoplasms
| Article | Year |
|---|---|
2,2'-Bipyridine-Modified Tamoxifen: A Versatile Vector for Molybdacarboranes.
Topics: 2,2'-Dipyridyl; Antineoplastic Agents; Boranes; Breast Neoplasms; Cell Line, Tumor; Cell Proliferati | 2019 |
Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents.
Topics: 2,2'-Dipyridyl; Amino Acids; Antineoplastic Agents; Breast Neoplasms; Cell Line; Cell Proliferation; | 2021 |
Effect of the FE
Topics: 2,2'-Dipyridyl; Antibiotics, Antineoplastic; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Line, Tum | 2018 |
Synthesis of [PtCl2(4,4'-dialkoxy-2,2'-bipyridine)] complexes and their in vitro anticancer properties.
Topics: 2,2'-Dipyridyl; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carbon; Cell Line, Tumor; Cell P | 2013 |
Copper (II) and 2,2'-bipyridine complexation improves chemopreventive effects of naringenin against breast tumor cells.
Topics: 2,2'-Dipyridyl; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Cell Prolifer | 2014 |
Migration of breast cancer cells into reconstituted type I collagen gels assessed via a combination of frozen sectioning and azan staining.
Topics: 2,2'-Dipyridyl; Azabicyclo Compounds; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Collagen Ty | 2014 |
A Novel Platinum-based Compound with Preferential Cytotoxic Activity against a Panel of Cancer Cell Lines.
Topics: 2,2'-Dipyridyl; Amniotic Fluid; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cisplatin; Dimet | 2016 |
Ruthenium(II) polypyridyl complexes: synthesis and studies of DNA binding, photocleavage, cytotoxicity, apoptosis, cellular uptake, and antioxidant activity.
Topics: 2,2'-Dipyridyl; Antineoplastic Agents; Antioxidants; Apoptosis; Breast Neoplasms; Cell Line, Tumor; | 2011 |
Cytotoxic property of surfactant-cobalt(III) complexes on a human breast cancer cell line.
Topics: 2,2'-Dipyridyl; Antineoplastic Agents; Apoptosis; Blotting, Western; Breast Neoplasms; Cell Line, Tu | 2011 |
Cytochemical application of tris (2,2'-bipyridine) ruthenium (II): fluorescence reaction with sulfated polyanions of mast cell granules.
Topics: 2,2'-Dipyridyl; Animals; Breast Neoplasms; Carcinoma; Coordination Complexes; Cytoplasmic Granules; | 1995 |
The effect of chelating agents on the distribution of monoclonal antibodies in mice.
Topics: 2,2'-Dipyridyl; Animals; Antibodies, Monoclonal; Breast Neoplasms; Chelating Agents; Deferoxamine; E | 1986 |